Long-Term Clinical Performance of Paclitaxel-Eluting Stents Coated With a Bioactive Polymer (P-5) Containing a Triflusal Derivative: Results of the REWAC Registry
OPEN The Journal of invasive cardiology | 6 Aug 2013
E García, A Serra, JJ Zueco, M Larman, JR Rumoroso, J Moreu, J Guarinos, MR Ortas, B Puigfel, A Rincón, K Ioannidis and N Piqué
Although drug-eluting stents have dramatically reduced angiographic restenosis and clinical need for repeat revascularization procedures, some adverse effects, such as late stent thrombosis, have been described. We evaluated clinical performance of paclitaxel-eluting stents coated with a new bioactive polymer system (P-5) based on a copolymer of an acrylic derivative of triflusal in patients with coronary artery disease.
* Data courtesy of Altmetric.com